AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
TETRAZEPAM
4 registrations across 3 African markets— 3 active
Markets with TETRAZEPAM
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| MYOZEPAM Comprimé pelliculé sécable / 50 MG | 🇹🇳Tunisia | DAR-ESSAYDALI. | expired | Dec 2006 |
| TETRAZEPAM ARROW comprimé pelliculé sécable / 50 mg | 🇸🇳Senegal | ARROW GENERIQUES | active | — |
| MYOLASTAN COMPRIME PELLICULE SECABLE | 🇲🇦Morocco | — | active | — |
| MUSARIL COMPRIME ENROBE | 🇲🇦Morocco | — | active | — |
TETRAZEPAM in Africa — Regulatory Overview
TETRAZEPAM is registered across 3 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Senegal, Tunisia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 3 (75%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.